37 articles
PCOS becomes PMOS in 2026 as 56 medical organizations recognize it as a metabolic disorder, shifting treatment from hormonal to insulin-focused care.
Women taking GLP-1 medications like Wegovy report unexpected benefits beyond weight loss, including reduced inflammation, improved fertility, and lower cancer...
GLP-1 medications like semaglutide achieve 15-20% weight loss in PCOS patients and improve insulin resistance independently of weight loss.
GLP-1 medications work differently in women due to hormonal interactions and sex-specific physiology.
UK researchers secured £60,000 in NHS funding to investigate whether GLP-1 drugs like Ozempic and Mounjaro can treat PCOS, a condition affecting 1 in 10 women...
Tirzepatide and similar GLP-1 drugs are emerging as potential PCOS treatments by targeting insulin resistance, the root cause affecting 8-13% of women.
A major study finds semaglutide users lose less muscle mass than tirzepatide users during weight loss, challenging the assumption that stronger weight loss...
New research suggests GLP-1 drugs like Ozempic may improve male fertility indirectly through weight loss and metabolic health, but direct effects remain...
Eli Lilly's new oral GLP-1 pill Foundayo and weekly injection Zepbound both help women lose weight, but clinical data shows Zepbound delivers significantly...
Researchers analyzing 400,000+ Reddit posts found unreported side effects of GLP-1 weight-loss drugs, including irregular periods and fever-like chills,...
GLP-1 is a hormone your body naturally produces to regulate appetite, but diet, age, and lifestyle can weaken it. Here's how to restore it.
OB-GYNs are increasingly prescribing Wegovy for weight management, especially for hormone-related conditions like PCOS. Here's how to talk to yours about it.
Semaglutide causes diarrhea in 74% of users, especially when starting or increasing doses. Here's why it happens and practical strategies to manage it.
Hair shedding affects up to 1 in 10 women on Mounjaro and many more on Ozempic and Wegovy.
UK medicines regulator investigates peptide clinics making unlawful health claims about unregulated therapies.
A Mayo Clinic study found postmenopausal women using hormone therapy with tirzepatide lost 35% more weight than those on the drug alone, suggesting a powerful...
GLP-1 medications like semaglutide and tirzepatide are showing unexpected benefits against kidney disease, heart disease, sleep apnea, and substance use...
36% of people with fibromyalgia live with obesity, worsening pain and fatigue. New research shows weight loss medications like Mounjaro may help break this...
Semaglutide delivers 15-20% weight loss versus phentermine's 5-10%, but works differently.
GLP-1 drugs like Ozempic are transforming weight loss treatment, but experts warn the cultural messaging around them mirrors toxic diet culture of the 1990s,...
TV presenter Alison Law warns that tirzepatide (Mounjaro) took a serious toll on her health, dropping to size 8 before recognizing the damage.
Stronger weight loss medications are arriving soon, with retatrutide showing 29% body weight loss in trials.
Three GLP-1 medications work through different hormonal pathways, producing 15-24% weight loss with varying side effects. Here's what sets them apart.
A viral 'natural Zepbound' drink made from apple cider vinegar and ginger has no scientific evidence supporting weight loss claims.
GLP-1 medications like Ozempic and Wegovy mimic a natural hormone to reduce appetite and regulate blood sugar, producing average weight loss of 15% of body...
Online semaglutide programs now cost $179-$199/month without insurance, slashing wait times from months to weeks.
GLP-1 drugs like Ozempic work best paired with diet and exercise, not alone. Here's what actually regulates your hormones.
GLP-1 weight loss drugs help some women lose 15% of body weight, but genetics, hormones, and metabolism determine who sees results.
Apple cider vinegar and cinnamon drinks went viral as a "natural Ozempic" alternative, but research shows modest effects.
Medical-grade body composition analysis reveals what bathroom scales miss: visceral fat, muscle loss, and metabolic rates.
New research shows women regain roughly 60% of lost weight within a year of stopping GLP-1 drugs like Ozempic, but retain about 25% long-term.
Your metabolism burns 60-75% of daily calories at rest, but standard calculators miss it by 200-600 calories.
Over 88 million American adults have prediabetes driven by insulin resistance, yet most don't know it.
Testosterone replacement therapy doesn't universally cause hair loss—genetics determine your risk.
Current human evidence doesn't support thyroid cancer risk from Ozempic, despite boxed warnings based on animal studies.
Oral semaglutide uses a special absorption enhancer to survive stomach acid, but demands fasting and precise timing.
Both oral and injectable Wegovy deliver similar weight loss results—around 14-15% average loss—but differ in convenience, adherence, and daily routines.
